Roche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of "Moderate Buy" by Analysts

Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) has received an average recommendation of "Moderate Buy" from the six research firms that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, one has assigned a hold recommendation, one has issued a buy recommendation and two have issued a strong buy recommendation on the company.

RHHBY has been the topic of a number of research analyst reports. Morgan Stanley assumed coverage on shares of Roche in a report on Wednesday, February 12th. They issued an "equal weight" rating on the stock. UBS Group raised shares of Roche from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 13th. Finally, Sanford C. Bernstein upgraded shares of Roche to a "strong-buy" rating in a research note on Thursday, January 30th.

Roche Stock Down 0.6 %

Roche stock opened at $39.52 on Monday. Roche has a 1-year low of $29.20 and a 1-year high of $44.31. The firm has a 50 day simple moving average of $40.76 and a 200 day simple moving average of $38.58. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of RHHBY. Bard Financial Services Inc. lifted its holdings in Roche by 37.7% in the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company's stock valued at $3,866,000 after acquiring an additional 30,350 shares during the period. Altrius Capital Management Inc boosted its position in shares of Roche by 0.3% during the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company's stock worth $6,399,000 after acquiring an additional 603 shares during the last quarter. Hancock Whitney Corp increased its stake in Roche by 6.8% in the 4th quarter. Hancock Whitney Corp now owns 23,516 shares of the company's stock worth $820,000 after acquiring an additional 1,496 shares during the last quarter. SVB Wealth LLC bought a new position in shares of Roche in the 4th quarter valued at about $555,000. Finally, Diversified Trust Co boosted its stake in shares of Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company's stock worth $2,130,000 after purchasing an additional 711 shares during the period.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.